In our study, single-cell sequencing results were used to study the use of tumour cell markers with a high proportion in cancer tissues, as well as EFNA4 and ETS1, in order to construct a prognostic model that can better predict the prognosis of patients with GC. The gene discussed is ETS1; the disease is cancer.